WATERTOWN, Mass.--(BUSINESS WIRE)--May 31, 2006--Acusphere, Inc. (NASDAQ: ACUS - News) announced today that it has scheduled a conference call to discuss the results from the first of two Phase 3 clinical trials for AI-700, the RAMP-1 trial. The call is scheduled for Tuesday, June 6, 2006. It is scheduled to commence at 7:00 a.m. EDT, prior to the Tuesday sessions of the American Society of Echocardiography. Participating on this call will include Sherri Oberg, President and CEO of Acusphere, Richard Walovitch, Ph.D., Senior Vice President of Clinical Research of Acusphere, and Roxy Senior, M.D., Director of Echocardiology in the Department of Cardiology at Northwick Park Hospital and the Imperial College School of Medicine, London UK, a leading thought leader in contrast echocardiography and largest enroller of patients in the RAMP-1 trial. Following opening comments, callers will have the opportunity to ask questions of the presenters.
